Knowledge Distillery

Dizziness and vertigo are common post-COVID-19-vaccination symptoms. In this article the authors aimed to prospectively evaluate objective central or…

In this paper, just published in Lancet, the authors performed a dose-escalation, single-centre, open-label, non-randomised, phase 1 trial of a…

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind,…

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind,…

In this study recently published in the New England Journal of Medicine, the authors conducted a phase 1, dose-escalation, open-label trial including…

In this article the authors isolated an infectious Delta strain from a traveller returning from India.

In this double-blind, randomised, placebo-controlled phase 3 trial the authors present the interim efficacy and safety results of a phase 3 clinical…

In this article the authors conducted a single-center, open-label, non-randomized, Phase 1 trial in India between July 2020 and October 2020.

In this article the authors assess 88 health care workers who had received one dose of ChAdOx1 nCoV-19 vaccine 9 to 12 weeks earlier. Among these…

In this article the authors used a test-negative case–control design to estimate the effectiveness of vaccination against symptomatic disease caused…